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In patients with heart failure caused by coronary ar-
tery disease (CAD), assessment of myocardial viability 
and successful revascularization seems to be crucial to 
improve the function of  the left ventricle. Importantly, 
available data are inconclusive regarding the usefulness 
of myocardial viability tests for the decision concerning 
revascularization in patients with left ventricular (LV) 
dysfunction and CAD [1]. Multiple observational studies 
have reported that viability imaging will be instrumental 
in such patients. However, data from prospective studies 
failed to confirm that [2].
A  55-year-old man, a  former smoker  with a  history 
of CAD and arterial hypertension, was admitted to our 
department to assess myocardial viability and the pos-
sibility of coronary revascularization. Two years before, 
he suffered from ST-segment elevation myocardial infarc-
tion of the antero-lateral wall successfully treated with 
percutaneous coronary intervention (PCI) of the left ante-
rior descending artery (LAD). Six months prior to admis-
sion the patient was hospitalized again at another ward 
due to unstable angina and underwent PCI of the right 
coronary artery. In the coronary angiogram ostial left 
circumflex artery  (Cx) stenosis was found (Figure 1 A). 
The patient reported symptoms of chronic heart failure 
(NYHA class III) and angina (CCS class II) with marked 
limitation of activities during normal exertion, with no 
symptoms at rest. The echocardiography showed severe 
systolic dysfunction of the LV with LV ejection fraction of 
13%, akinesis with thinning of the medial segment of lat-
eral wall, akinesis of the septum, 2/3 distal of the anteri-
or and posterior walls and significant hypokinesis of the 
inferior wall and basal segments of the posterior and an-
terior walls of the LV. No significant valvular disease was 
revealed. Dobutamine stress echocardiography (DSE) 
(15 μg/kg/min) did not confirm the presence of contrac-
tile reserve of the LV. However, due to symptoms of angina 
the diagnostics were expanded by single-photon emis-
sion computed tomography (SPECT) and F18-fluorodeox-
yglucose positron emission tomography (PET). The SPECT 
examination, using technetium-99m sestamibi, was per-
formed. The level of the pharmaceutical agent uptake at 
rest in the lateral wall (more than 50% of maximal up-
take) suggested preserved viability. The patient exercised 
on the treadmill to a maximum load of 7.9 MET. After ex-
ercise, the examination revealed evidence of a transient 
perfusion defect in the infero-lateral wall (worse perfu-
sion in stress oblique/coronal slices 70-67 in row C than 
in the corresponding rest slices 79-76 in row B). Addition-
ally, PET imaging showed the presence of heterogeneous 
acquisition of the glucose radiotracer in the segments of 
the lateral wall (Figure 2). Transiency of SPECT perfusion 
defects and the heterogeneous acquisition might be con-
sidered as proof of myocardial viability and suggest a po-
tential benefit from myocardial revascularization.
Due to extremely reduced LV ejection fraction and 
high risk of periprocedural complications, an LV assist de-
vice (HeartMate PHP, Thoratec Corporation, CA, USA) was 
used during PCI. The procedure was performed by the 
femoral access. After the balloon predilation (2.5 × 20 mm; 
14 atm) in LMCA and Cx, implantation of a  drug-elut-
ing stent, Xience 3.0/23 mm (Abbott Vascular – Santa 
Clara, USA), up to 12–16 atm, was performed. Then, the 
proximal optimization technique with a  non-compliant 
balloon (3.5 × 8 mm, 16 atm) was applied. Finally, the 
kissing balloons technique was used (Figure 1 B). No pro-
cedure-related complications were observed.
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The previous pharmacological treatment of heart fail-
ure was maintained. The patient had no indications for 
cardiac resynchronization therapy. After 1 year, the LV 
ejection fraction was increased up to 21%. The most im-
portant effect was a significant reduction in the severity of 
symptoms and increased exercise tolerance (NYHA class I). 
Akinesis of the walls of the LV is regarded as an ir-
reversible condition and diagnostics of heart failure is 
not extended in such cases. In this particular case DSE 
was not sufficient to confirm myocardial viability, which 
however was confirmed by SPECT and PET imaging. 
The PET has higher sensitivity for the detection of viability 
Figure 2. Assessment of myocardial viability by nuclear imaging techniques before intervention: A – F18-flu-
orodeoxyglucose positron emission tomography, B – single-photon emission computed tomography using 
technetium-99m sestamibi – Rest, C – single-photon emission computed tomography using technetium-99m 
sestamibi – Stress – after exercise treadmill test. The SPECT (B, C) and PET (A) showed that in the segments of 
the lateral wall acquisition of the radiotracer was present
Figure 1. Ostial left circumflex artery stenosis before (A) and after (B) percutaneous coronary intervention 
with left ventricular assist device support. HeartMate PHP device marked with *; Stenosis and effect of 
interventions marked with arrows
A B
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but has lower specificity in comparison to DSE and SPECT 
[3, 4]. The PCI with use of the LV assist device as peripro-
cedural hemodynamic support may be a  feasible and 
safe revascularization method in high-risk patients with 
severe heart failure or excessive comorbidities [5].
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